Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm
Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm
Read moreHemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm
Read moreHemogenyx Interim Loss Widens But CDX Antibody Work Progresses
Read more(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement with cell therapy outfit Orgenesis to further commercialise its humanised-mouse drug model.
Read more(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement industry giant Johnson and Johnson to develop a model of systemic lupus erythematosus, the most common form of Lupus.
Read moreLONDON (Alliance News) - Biotechnology company Hemogenyx Pharmaceuticals PLC said on Tuesday it has appointed Marc Feldmann as executive chairman, with effect next will be who
Read more